Found: 53
Select item for more details and to access through your institution.
Prognostic impact of serum CYFRA 21-1 in patients with advanced lung adenocarcinoma: a retrospective study.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Surfactant protein-D predicts prognosis of interstitial lung disease induced by anticancer agents in advanced lung cancer: a case control study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Cerebral infarction in advanced non-small cell lung cancer: a case control study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Early Detection of Therapeutic Benefit from PD-1/PD-L1 Blockade in Advanced Lung Cancer by Monitoring Cachexia-Related Circulating Cytokines.
- Published in:
- Cancers, 2023, v. 15, n. 4, p. 1170, doi. 10.3390/cancers15041170
- By:
- Publication type:
- Article
Clinical Significance of Tumor Markers for Advanced Thymic Carcinoma: A Retrospective Analysis from the NEJ023 Study.
- Published in:
- Cancers, 2022, v. 14, n. 2, p. 331, doi. 10.3390/cancers14020331
- By:
- Publication type:
- Article
Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung disease.
- Published in:
- BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-508
- By:
- Publication type:
- Article
Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung disease.
- Published in:
- BMC Cancer, 2014, v. 14, n. 1, p. 508, doi. 10.1186/1471-2407-14-508
- By:
- Publication type:
- Article
Progression-free survival at 2 years is a reliable surrogate marker for the 5-year survival rate in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy.
- Published in:
- BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-18
- By:
- Publication type:
- Article
Progression-free survival at 2 years is a reliable surrogate marker for the 5-year survival rate in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung disease.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Activity of EGFR-tyrosine kinase and ALK inhibitors for EML4-ALK-rearranged non-small-cell lung cancer harbored coexisting EGFR mutation.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Clinical Outcomes of Second‐Line Chemotherapy in Patients with Previously Treated Advanced Thymic Carcinoma: A Retrospective Analysis of 191 Patients from the NEJ023 Study.
- Published in:
- Oncologist, 2020, v. 25, n. 4, p. e668, doi. 10.1634/theoncologist.2019-0593
- By:
- Publication type:
- Article
Prognostic Factors and Efficacy of First‐Line Chemotherapy in Patients with Advanced Thymic Carcinoma: A Retrospective Analysis of 286 Patients from NEJ023 Study.
- Published in:
- Oncologist, 2018, v. 23, n. 10, p. 1210, doi. 10.1634/theoncologist.2017-0586
- By:
- Publication type:
- Article
An immunogold single extracellular vesicular RNA and protein (<sup>Au</sup>SERP) biochip to predict responses to immunotherapy in non‐small cell lung cancer patients.
- Published in:
- Journal of Extracellular Vesicles, 2022, v. 11, n. 9, p. 1, doi. 10.1002/jev2.12258
- By:
- Publication type:
- Article
CALML5 is a novel diagnostic marker for differentiating thymic squamous cell carcinoma from type B3 thymoma.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 12, p. 1089, doi. 10.1111/1759-7714.14853
- By:
- Publication type:
- Article
Clinical characteristics of adrenal insufficiency induced by pembrolizumab in non-small-cell lung cancer.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 5, p. 442, doi. 10.1111/1759-7714.14761
- By:
- Publication type:
- Article
Successful restart of chemotherapy in a patient with primary mediastinal nonseminomatous germ cell tumor after COVID‐19 infection.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 18, p. 2654, doi. 10.1111/1759-7714.14593
- By:
- Publication type:
- Article
Zinc‐finger E‐box‐binding homeobox 1 (ZEB1) plays a crucial role in the maintenance of lung cancer stem cells resistant to gefitinib.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 10, p. 1536, doi. 10.1111/1759-7714.13937
- By:
- Publication type:
- Article
Transformation from adenocarcinoma to squamous cell lung carcinoma with MET amplification after lorlatinib resistance: A case report.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 5, p. 715, doi. 10.1111/1759-7714.13829
- By:
- Publication type:
- Article
Impact of the generation of EGFR‐TKIs administered as prior therapy on the efficacy of osimertinib in patients with non‐small cell lung cancer harboring EGFR T790M mutation.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 3, p. 329, doi. 10.1111/1759-7714.13742
- By:
- Publication type:
- Article
Activation of insulin‐like growth factor‐1 receptor confers acquired resistance to osimertinib in non‐small cell lung cancer with EGFR T790M mutation.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 1, p. 140, doi. 10.1111/1759-7714.13255
- By:
- Publication type:
- Article
Differences in the efficacy of S-1 monotherapy according to histological type in pretreated patients with advanced non-small cell lung cancer.
- Published in:
- Thoracic Cancer, 2014, v. 5, n. 2, p. 121, doi. 10.1111/1759-7714.12071
- By:
- Publication type:
- Article
Association between the efficacy and immune-related adverse events of pembrolizumab and chemotherapy in non-small cell lung cancer patients: a retrospective study.
- Published in:
- BMC Cancer, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12885-022-10133-1
- By:
- Publication type:
- Article
Actual status of adjuvant chemotherapy for non-small-cell lung cancer at one Japanese cancer center: the need for increased cooperation between medical oncologists and surgeons.
- Published in:
- Medical Oncology, 2010, v. 27, n. 3, p. 932, doi. 10.1007/s12032-009-9309-6
- By:
- Publication type:
- Article
A multicenter phase II trial of S-1 combined with bevacizumab after platinum-based chemotherapy in patients with advanced non-squamous non-small cell lung cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Prognostic factors in non-small cell lung cancer patients who are recommended to receive single-agent chemotherapy (docetaxel or pemetrexed) as a second- or third-line chemotherapy: in the era of oncogenic drivers and molecular-targeted agents.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Size-Based Isolation of Circulating Tumor Cells in Lung Cancer Patients Using a Microcavity Array System.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0067466
- By:
- Publication type:
- Article
The efficacy of amrubicin on central nervous system metastases originating from small-cell lung cancer: a case series of eight patients.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 3, p. 755, doi. 10.1007/s10637-015-0233-7
- By:
- Publication type:
- Article
Epidemiology, risk factors and impact of cachexia on patient outcome: Results from the Japanese Lung Cancer Registry Study.
- Published in:
- Journal of Cachexia, Sarcopenia & Muscle, 2023, v. 14, n. 3, p. 1274, doi. 10.1002/jcsm.13216
- By:
- Publication type:
- Article
Pattern of care in adjuvant therapy for resected Stage I non-small cell lung cancer: real-world data from Japan.
- Published in:
- Japanese Journal of Clinical Oncology, 2019, v. 49, n. 1, p. 63, doi. 10.1093/jjco/hyy165
- By:
- Publication type:
- Article
Multicenter observational cohort study of post-operative treatment for completely resected non-small-cell lung cancer of pathological Stage I (T1 >2 cm and T2 in TNM classification version 6).
- Published in:
- Japanese Journal of Clinical Oncology, 2015, v. 45, n. 5, p. 499, doi. 10.1093/jjco/hyv028
- By:
- Publication type:
- Article
Chemoradiotherapy for Limited-disease Small-cell Lung Cancer in Elderly Patients Aged 75 Years or Older.
- Published in:
- Japanese Journal of Clinical Oncology, 2013, v. 43, n. 2, p. 176, doi. 10.1093/jjco/hys197
- By:
- Publication type:
- Article
Weekly Paclitaxel After Failure of Gemcitabine in Pancreatic Cancer Patients with Malignant Ascites: A Retrospective Study.
- Published in:
- Japanese Journal of Clinical Oncology, 2010, v. 40, n. 12, p. 1135, doi. 10.1093/jjco/hyq117
- By:
- Publication type:
- Article
Evaluation of the Safety and Compliance of 3-Week Cycles of Vinorelbine on Days 1 and 8 and Cisplatin on Day 1 as Adjuvant Chemotherapy in Japanese Patients with Completely Resected Pathological Stage IB to IIIA Non-small Cell Lung Cancer: A ...
- Published in:
- Japanese Journal of Clinical Oncology, 2009, v. 39, n. 3, p. 158
- By:
- Publication type:
- Article
Hermansky-Pudlak syndrome-associated pneumothorax with rapid progression of respiratory failure: a case report.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Real‐world therapeutic effectiveness of lorlatinib after alectinib in Japanese patients with ALK‐positive non‐small‐cell lung cancer.
- Published in:
- Cancer Science, 2023, v. 114, n. 6, p. 2560, doi. 10.1111/cas.15777
- By:
- Publication type:
- Article
High levels of AXL expression in untreated EGFR‐mutated non‐small cell lung cancer negatively impacts the use of osimertinib.
- Published in:
- Cancer Science, 2023, v. 114, n. 2, p. 606, doi. 10.1111/cas.15608
- By:
- Publication type:
- Article
Highly sensitive fusion detection using plasma cell‐free RNA in non‐small‐cell lung cancers.
- Published in:
- Cancer Science, 2021, v. 112, n. 10, p. 4393, doi. 10.1111/cas.15084
- By:
- Publication type:
- Article
A Japanese lung cancer registry study on demographics and treatment modalities in medically treated patients.
- Published in:
- Cancer Science, 2020, v. 111, n. 5, p. 1685, doi. 10.1111/cas.14368
- By:
- Publication type:
- Article
Efficacy of gefitinib for non-adenocarcinoma non-small-cell lung cancer patients harboring epidermal growth factor receptor mutations: A pooled analysis of published reports.
- Published in:
- Cancer Science, 2011, v. 102, n. 5, p. 1032, doi. 10.1111/j.1349-7006.2011.01887.x
- By:
- Publication type:
- Article
Extrapleural air secondary to idiopathic pulmonary fibrosis-related pneumomediastinum.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Progression-free survival, post-progression survival, and tumor response as surrogate markers for overall survival in patients with extensive small cell lung cancer.
- Published in:
- Annals of Thoracic Medicine, 2015, v. 10, n. 1, p. 61, doi. 10.4103/1817-1737.146885
- By:
- Publication type:
- Article
The effect of gefitinib in patients with postoperative recurrent non-small cell lung cancer harboring mutations of the epidermal growth factor receptor.
- Published in:
- International Journal of Clinical Oncology, 2015, v. 20, n. 4, p. 668, doi. 10.1007/s10147-014-0761-8
- By:
- Publication type:
- Article
Comparison of chemotherapeutic efficacy between LCNEC diagnosed using large specimens and possible LCNEC diagnosed using small biopsy specimens.
- Published in:
- International Journal of Clinical Oncology, 2014, v. 19, n. 1, p. 63, doi. 10.1007/s10147-012-0509-2
- By:
- Publication type:
- Article
The role of βIII-tubulin in non-small cell lung cancer patients treated by taxane-based chemotherapy.
- Published in:
- International Journal of Clinical Oncology, 2013, v. 18, n. 3, p. 371, doi. 10.1007/s10147-012-0386-8
- By:
- Publication type:
- Article
Erratum to: Evaluation of S-1 as third- or further-line chemotherapy in advanced non-small-cell lung cancer.
- Published in:
- 2010
- By:
- Publication type:
- Correction notice
Comparison of chemotherapy regimens for concurrent chemoradiotherapy in unresectable stage III non-small cell lung cancer.
- Published in:
- International Journal of Clinical Oncology, 2009, v. 14, n. 6, p. 507, doi. 10.1007/s10147-009-0907-2
- By:
- Publication type:
- Article
Efficacy and Safety of Platinum Combination Chemotherapy Re-Challenge for Relapsed Patients with Non-Small-Cell Lung Cancer after Postoperative Adjuvant Chemotherapy of Cisplatin plus Vinorelbine.
- Published in:
- Chemotherapy (0009-3157), 2014, v. 59, n. 4, p. 307, doi. 10.1159/000356155
- By:
- Publication type:
- Article
Lymphangioleiomyomatosis as a potent lung cancer risk factor: Insights from a Japanese large cohort study.
- Published in:
- Respirology, 2024, v. 29, n. 9, p. 815, doi. 10.1111/resp.14724
- By:
- Publication type:
- Article
Efficacy of platinum agents for stage III non-small-cell lung cancer following platinum-based chemoradiotherapy: a retrospective study.
- Published in:
- 2022
- By:
- Publication type:
- journal article